Chinese Japanese Germany Korea

3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]propanamide

3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]propanamide Structure
3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]propanamide structure
CAS No.
2058397-37-6
Chemical Name:
3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]propanamide
Synonyms
3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]propanamide;1H-1,4-Benzodiazepine-3-propanamide, 2,3,4,5-tetrahydro-N-[[3-[4-(1-methylethoxy)phenyl]-1,2,4-oxadiazol-5-yl]methyl]-2,5-dioxo-
CBNumber:
CB34350629
Molecular Formula:
C24H25N5O5
Molecular Weight:
463.49
MDL Number:
MOL File:
2058397-37-6.mol
Request For Quotation

3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]propanamide Properties

Density 1.258±0.06 g/cm3(Predicted)
pka 12.67±0.40(Predicted)

3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]propanamide Preparation Products And Raw materials

Raw materials

Preparation Products

3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]propanamide Suppliers

Global( 1)Suppliers
Supplier Tel Email Country ProdList Advantage
PHARMEKS Ltd. -- sales@pharmeks.com Finland 6350 50
Supplier Advantage
PHARMEKS Ltd. 50
3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[[3-(4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]propanamide 1H-1,4-Benzodiazepine-3-propanamide, 2,3,4,5-tetrahydro-N-[[3-[4-(1-methylethoxy)phenyl]-1,2,4-oxadiazol-5-yl]methyl]-2,5-dioxo- 2058397-37-6